General Manager, New Ventures
Mon, Feb 14, 2022
Feb 14
exercised or converted securities in EXAS
2,030 shares @ $78.33
Increased holdings by +37.30%
Option Exercise
Sale tied to a same-time option exercise
EXASEXACT SCIENCES CORP
Health CareHealth Care Services